Contact Us

Articles Tagged: MDCG

MDCG Guidance on EU Authorised Representatives Released: MDCG 2022-16

This document is long overdue, however, here it is! The MDCG 2022-16 Guidance on Authorised Representatives concerning Regulations (EU) 2017/745 & 2017/746. It lays out what medical device manufacturers should expect as a minimum from their appointment EU Authorised Representative. There are some interesting elements of the Regulations explained and clarified as guidance and as ...

MDCG 2022-9: Summary of Safety and Performance Template

The MDCG have published a template for the Summary of Safety and Performance (SSP) as required by the EU IVD Regulation 2017/746 (IVDR) for Class C and Class D devices. The format of the SSP will depend on whether the device used is intended for self-testing. If it is not, then there shall be another ...

MDCG 2022-8: Application of IVDR to Legacy Devices

As most IVD manufacturers will know, a derogation to the IVDR was passed earlier this year which allows for a stepped transition in accordance with Article 110(3) of the IVDR. This allows for General IVDs registered under the IVD Directive which will require Notified Body intervention under the Regulation an extended transition period. However, there ...

MDCG 2022-7: UDI System Q&A

A Q&A document on the EU Regulation’s Unique Device Identification (UDI) system has been published to answer some of the most burning questions when it comes to the application of UDI to medical devices and IVDs. The document covers the following themes: UDI-DI. Basic UDI-DI (BUDI). UDI Labelling. UDI Rules for System and Procedure Packs ...

Advena.mt Logo Website
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.